Human IgE-independent systemic anaphylaxis

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 6, 2016, Pages 1674-1680

  Finkelman, Fred D ^a,b,c   Khodoun, Marat V ^a,b   Strait, Richard ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Anaphylatoxin; basophil; complement; Fc R; Fc R; IgE; IgG; mast cell; mouse

Indexed keywords

IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; COMPLEMENT; IMMUNOGLOBULIN E RECEPTOR;

HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC ANAPHYLAXIS; ANAPHYLAXIS; ANIMAL; BASOPHIL; DISEASE MODEL; DRUG HYPERSENSITIVITY; IMMUNOLOGY; MAST CELL; METABOLISM; MOUSE;

ANAPHYLAXIS; ANIMALS; BASOPHILS; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; DRUG HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MAST CELLS; MICE; RECEPTORS, IGE;

EID: 84964647514     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.02.015     Document Type: Article

References (60)

1. B.S. Bochner, and L.M. Lichtenstein Anaphylaxis N Engl J Med 324 1991 1785 1790
2. W.W. Decker, R.L. Campbell, V. Manivannan, A. Luke, J.L. St Sauver, A. Weaver, and et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project J Allergy Clin Immunol 122 2008 1161 1165
3. T. Ishizaka, K. Ishizaka, and H. Tomioka Release of histamine and slow reacting substance of anaphylaxis (SRS-A) by IgE-anti-IgE reactions on monkey mast cells J Immunol 108 1972 513 520
4. L.B. Schwartz Effector cells of anaphylaxis: mast cells and basophils Novartis Found Symp 257 2004 65 79 98-100, 276-85
5. N. Hirayama, T. Hirano, G. Kohler, A. Kurata, K. Okumura, and Z. Ovary Biological activities of antitrinitrophenyl and antidinitrophenyl mouse monoclonal antibodies Proc Natl Acad Sci U S A 79 1982 613 615
6. E.B. Brandt, R.T. Strait, D. Hershko, Q. Wang, E.E. Muntel, T.A. Scribner, and et al. Mast cells are required for experimental oral allergen-induced diarrhea J Clin Invest 112 2003 1666 1677
7. Z.Y. Kucuk, R. Strait, M. Khodoun, A. Mahler, S. Hogan, and F.D. Finkelman Induction and suppression of allergic diarrhea and systemic anaphylaxis in a mouse model of food allergy J Allergy Clin Immunol 129 2012 1343 1348
8. R.T. Strait, A. Mahler, S. Hogan, M. Khodoun, A. Shibuya, and F.D. Finkelman Ingested allergens must be absorbed systemically to induce systemic anaphylaxis J Allergy Clin Immunol 127 2011 982 989.e1
9. T. Takeishi, T.R. Martin, I.M. Katona, F.D. Finkelman, and S.J. Galli Differences in the expression of the cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. Mast cells are not required for the cardiopulmonary changes associated with certain fatal anaphylactic responses J Clin Invest 88 1991 598 608
10. I. Miyajima, D. Dombrowicz, T.R. Martin, J.V. Ravetch, J.P. Kinet, and S.J. Galli Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1- dependent passive anaphylaxis J Clin Invest 99 1997 901 914
11. R.T. Strait, S.C. Morris, M. Yang, X.W. Qu, and F.D. Finkelman Pathways of anaphylaxis in the mouse J Allergy Clin Immunol 109 2002 658 668
12. M.V. Khodoun, Z.Y. Kucuk, R.T. Strait, D. Krishnamurthy, K. Janek, C.D. Clay, and et al. Rapid desensitization of mice with anti-FcγRIIb/FcγRIII mAb safely prevents IgG-mediated anaphylaxis J Allergy Clin Immunol 132 2013 1375 1387
13. D. Dombrowicz, V. Flamand, I. Miyajima, J.V. Ravetch, S.J. Galli, and J.P. Kinet Absence of FcϵRIα chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between FcϵRI and FcγRIII for limiting amounts of FcR β and γ chains J Clin Invest 99 1997 915 925
14. H.C. Oettgen, T.R. Martin, A. Wynshaw-Boris, C. Deng, J.M. Drazen, and P. Leder Active anaphylaxis in IgE-deficient mice Nature 370 1994 367 370
15. R.T. Strait, S.C. Morris, and F.D. Finkelman IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking J Clin Invest 116 2006 833 841
16. M. Khodoun, Z.Y. Kucuk, R.T. Strait, D. Krishnamurthy, K. Janek, I.P. Lewkowich, and et al. Rapid polyclonal desensitization with antibodies to IgE and FcϵRIα J Allergy Clin Immunol 133 2013 1555 1564
17. H.M. Grey, J.W. Hirst, and M. Cohn A new mouse immunoglobulin: IgG3 J Exp Med 133 1971 289 304
18. F. Nimmerjahn, P. Bruhns, K. Horiuchi, and J.V. Ravetch FcγRIV: a novel FcR with distinct IgG subclass specificity Immunity 23 2005 41 51
19. F. Jonsson, D.A. Mancardi, Y. Kita, H. Karasuyama, B. Iannascoli, N. Van Rooijen, and et al. Mouse and human neutrophils induce anaphylaxis J Clin Invest 121 2011 1484 1496
20. Y. Tsujimura, K. Obata, K. Mukai, H. Shindou, M. Yoshida, H. Nishikado, and et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis Immunity 28 2008 581 589
21. F. Nimmerjahn, and J.V. Ravetch Divergent Immunoglobulin G subclass activity through selective Fc receptor binding Science 310 2005 1510 1512
22. J.M. Mencia-Huerta, and J. Benveniste Platelet-activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes Eur J Immunol 9 1979 409 415
23. M. Sanchez-Crespo, F. Alonso, and J. Egido Platelet-activating factor in anaphylaxis and phagocytosis. I. Release from human peripheral polymorphonuclears and monocytes during the stimulation by ionophore A23187 and phagocytosis but not from degranulating basophils Immunology 40 1980 645 655
24. P. Bruhns, and F. Jonsson Mouse and human FcR effector functions Immunol Rev 268 2015 25 51
25. T. Takai, M. Ono, M. Hikida, H. Ohmori, and J.V. Ravetch Augmented humoral and anaphylactic responses in FcγRII-deficient mice Nature 379 1996 346 349
26. C. Schmidt-Lauber, L. Bossaller, H.H. Abujudeh, G.I. Vladimer, A. Christ, K.A. Fitzgerald, and et al. Gadolinium-based compounds induce NLRP3-dependent IL-1β production and peritoneal inflammation Ann Rheum Dis 74 2015 2062 2069
27. P. Vadas, M. Gold, B. Perelman, G.M. Liss, G. Lack, T. Blyth, and et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis N Engl J Med 358 2008 28 35
28. P. Vadas, B. Perelman, and G. Liss Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis J Allergy Clin Immunol 131 2012 144 149
29. A. Ujike, Y. Ishikawa, M. Ono, T. Yuasa, T. Yoshino, M. Fukumoto, and et al. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG J Exp Med 189 1999 1573 1579
30. W. Zhao, C.L. Kepley, P.A. Morel, L.M. Okumoto, Y. Fukuoka, and L.B. Schwartz FcγRIIa, not FcγRIIb, is constitutively and functionally expressed on skin-derived human mast cells J Immunol 177 2006 694 701
31. J.J. Lee, and M.P. McGarry When is a mouse basophil not a basophil? Blood 109 2007 859 861
32. A. Cheifetz, M. Smedley, S. Martin, M. Reiter, G. Leone, L. Mayer, and et al. The incidence and management of infusion reactions to infliximab: a large center experience Am J Gastroenterol 98 2003 1315 1324
33. A.P. Schmidt, H.F. Taswell, and G.J. Gleich Anaphylactic transfusion reactions associated with anti-IgA antibody N Engl J Med 280 1969 188 193
34. C. Steenholdt, M. Svenson, K. Bendtzen, O.O. Thomsen, J. Brynskov, and M.A. Ainsworth Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's disease J Crohns Colitis 6 2012 108 111
35. H. Hedin, W. Richter, K. Messmer, H. Renck, K.G. Ljungstrom, and H. Laubenthal Incidence, pathomechanism and prevention of dextran-induced anaphylactoid/anaphylactic reactions in man Dev Biol Stand 48 1980 179 189
36. Y. Umeda, Y. Fukumoto, T. Miyauchi, M. Imaizumi, K. Shimabukuro, Y. Mori, and et al. Anaphylactic shock related to aprotinin induced by anti-aprotinin immunoglobulin G antibody alone; report of a case Kyobu Geka 60 2007 69 71
37. L. Bergamaschini, P.M. Mannucci, A.B. Federici, R. Coppola, S. Guzzoni, and A. Agostoni Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor J Lab Clin Med 125 1995 348 355
38. K. Farnam, C. Chang, S. Teuber, and M.E. Gershwin Nonallergic drug hypersensitivity reactions Int Arch Allergy Immunol 159 2012 327 345
39. E. Miele, J.E. Markowitz, P. Mamula, and R.N. Baldassano Human antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximab J Pediatr Gastroenterol Nutr 38 2004 502 508
40. F. Baert, M. Noman, S. Vermeire, G. Van Assche, G. D'Haens, A. Carbonez, and et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease N Engl J Med 348 2003 601 608
41. J.M. Mencia-Huerta, R.A. Lewis, E. Razin, and K.F. Austen Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE J Immunol 131 1983 2958 2964
42. L.B. Schwartz Mediators of human mast cells and human mast cell subsets Ann Allergy 58 1987 226 235
43. J. van der Heijden, J. Geissler, E. van Mirre, M. van Deuren, J.W. van der Meer, A. Salama, and et al. A novel splice variant of FcγRIIa: a risk factor for anaphylaxis in patients with hypogammaglobulinemia J Allergy Clin Immunol 131 2013 1408 1416.e5
44. J. Szebeni Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity Toxicology 216 2005 106 121
45. B. Schafer, A.M. Piliponsky, T. Oka, C.H. Song, N.P. Gerard, C. Gerard, and et al. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice J Allergy Clin Immunol 131 2013 541 548 e1-9
46. M. Khodoun, R. Strait, T. Orekov, S. Hogan, H. Karasuyama, D.R. Herbert, and et al. Peanuts can contribute to anaphylactic shock by activating complement J Allergy Clin Immunol 123 2009 342 351
47. T. Kodama, H. Sekine, M. Takahashi, D. Iwaki, T. Machida, K. Kanno, and et al. Role of complement in a murine model of peanut-induced anaphylaxis Immunobiology 218 2013 844 850
48. J. Szebeni Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals Mol Immunol 61 2014 163 173
49. D.E. Van Epps, S.J. Simpson, and R. Johnson Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a J Immunol 150 1993 246 252
50. D.E. Van Epps, S.J. Simpson, and D.E. Chenoweth C5a and formyl peptide receptor regulation on human monocytes J Leukoc Biol 51 1992 393 399
51. W. Füreder, H. Agis, M. Willheim, H.C. Bankl, U. Maier, K. Kishi, M.R. Müller, and et al. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells J Immunol 155 1995 3152 3160
52. J.M. Skeie, J.H. Fingert, S.R. Russell, E.M. Stone, and R.F. Mullins Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells Invest Ophthalmol Vis Sci 51 2010 5336 5342
53. S.G. Brown, S.F. Stone, D.M. Fatovich, S.A. Burrows, A. Holdgate, A. Celenza, and et al. Anaphylaxis: clinical patterns, mediator release, and severity J Allergy Clin Immunol 132 2013 1141 1149.e5
54. P.W. van der Linden, C.E. Hack, J.A. Kerckhaert, A. Struyvenberg, and J.C. van der Zwan Preliminary report: complement activation in wasp-sting anaphylaxis Lancet 336 1990 904 906
55. B.D. McNeil, P. Pundir, S. Meeker, L. Han, B.J. Undem, M. Kulka, and et al. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions Nature 519 2015 237 241
56. H. Matsuo, T. Yokooji, H. Morita, M. Ooi, K. Urata, K. Ishii, and et al. Aspirin augments IgE-mediated histamine release from human peripheral basophils via Syk kinase activation Allergol Int 62 2013 503 511
57. T.K. Kishimoto, K. Viswanathan, T. Ganguly, S. Elankumaran, S. Smith, K. Pelzer, and et al. Contaminated heparin associated with adverse clinical events and activation of the contact system N Engl J Med 358 2008 2457 2467
58. M. Veien, F. Szlam, J.T. Holden, K. Yamaguchi, D.D. Denson, and J.H. Levy Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells Anesthesiology 92 2000 1074 1081
59. N. Mushlin, B. Vahid, and R. Roberts Use of naloxone in hydromorphone-induced anaphylactoid reaction South Med J 100 2007 611
60. E. Liu, H. Moriyama, N. Abiru, D. Miao, L. Yu, R.M. Taylor, and et al. Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9-23 and B:13-23 J Clin Invest 110 2002 1021 1027